Masilukast

DB16227InvestigationalSmall molecule

Masilukast is under investigation in clinical trial NCT01740986 (Safety and Efficacy of SA09012 in Asthma).

Chemical structure of Masilukast
Formula / weight
C31H32F3N3O5S · 615.67 g/mol (avg)
Code names
ICI-D3523 · MCC-847 · SA-09012 · ZD-3523

Resolves to

Compound
UNII2QJ3R1H23SCAS136564-68-6ChEMBLCHEMBL442263
Structure
InChIKeyULMFXAMQUGLVGA-LJQANCHMSA-NSMILESCOC1=CC(=CC=C1CC1=CN(C)C2=C1C=C(C=C2)C(=O)NC[C@H](C)CC(F)(F)F)C(=O)NS(=O)(=O)C1=CC=CC=C1C
Targets
Q9Y271CYSLTR1

What you can answer from here — as of January 29, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Masilukast, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In